Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore

ESMO rare cancers.

  • h-index: 0
  • Total citations: 0
  • Total papers: 0
    • 0

Homepage: https://www.sciencedirect.com/

ESMO rare cancers.

Journal
Visit website →
H-Index = 0
Citations = 0

Papers

Evidence

Recent papers in ESMO rare cancers.

  1. Enteric-type urachal adenocarcinoma harboring an EIF3E::RSPO2 fusion with durable response to immune checkpoint inhibition: a case reportESMO rare cancers. · Thu,
  2. Epidemiology of sinonasal undifferentiated carcinoma in Queensland, Australia, 1982-2024: insights from a population-based cohortESMO rare cancers. · Fri,
  3. Long-term impact of sporadic desmoid fibromatosis on work life, reproductive health, and support needs: results from the PROSa-DES studyESMO rare cancers. · Tue,
  4. Feasibility of active surveillance for atypical lipomatous tumors and impact on quality of life: interim analysis of the MINIMALIST trialESMO rare cancers. · Tue,
  5. Enhancing the attractiveness of sarcoma drug development: from rare disease to high-value development platformESMO rare cancers. · Tue,
  6. Unusual metastatic patterns in gastrointestinal stromal tumors: a multicenter analysis from the Dutch GIST RegistryESMO rare cancers. · Tue,
  7. Cellularity in myxoid liposarcoma: association with tumor immune microenvironment and patient outcomesESMO rare cancers. · Wed,
  8. Precision oncology in salivary gland cancer: molecular landscape, therapeutic advances and emerging strategiesESMO rare cancers. · Wed,
  9. Risk factors and outcome for children, adolescents and young adults with grossly resected (IRS group I/II) non-rhabdomyosarcoma soft tissue sarcomasESMO rare cancers. · Tue,
  10. Trials for rare cancers are more successful than those for common cancersESMO rare cancers. · Tue,

About ESMO rare cancers.

The journal's official homepage is at https://www.sciencedirect.com/.

Use the feed below to follow new ESMO rare cancers. publications with AI-enriched analysis — each paper is decomposed into study design, population, intervention, comparator, primary outcome, and key finding, with the underlying evidence traceable to the primary source.

Deterministic synthesis from Synapse's enriched records — 46 words.